EE158 Healthcare Resource Utilization and Costs Among Medicare Beneficiaries Initiating Venetoclax Vs. Btkis for Relapsed/Refractory Chronic Lymphocytic Leukemia: A Real-World Study
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.461
https://www.valueinhealthjournal.com/article/S1098-3015(23)00561-2/fulltext
Title :
EE158 Healthcare Resource Utilization and Costs Among Medicare Beneficiaries Initiating Venetoclax Vs. Btkis for Relapsed/Refractory Chronic Lymphocytic Leukemia: A Real-World Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00561-2&doi=10.1016/j.jval.2023.03.461
First page :
Section Title :
Open access? :
No
Section Order :
11843